Acoustic Mist Ionization Platform for Direct and Contactless Ultrahigh-Throughput Mass Spectrometry Analysis of Liquid Samples.


Journal

Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536

Informations de publication

Date de publication:
19 03 2019
Historique:
pubmed: 6 3 2019
medline: 1 9 2020
entrez: 6 3 2019
Statut: ppublish

Résumé

Mass spectrometry (MS) has many advantages as a quantitative detection technology for applications within drug discovery. However, current methods of liquid sample introduction to a detector are slow and limit the use of mass spectrometry for kinetic and high-throughput applications. We present the development of an acoustic mist ionization (AMI) interface capable of contactless nanoliter-scale "infusion" of up to three individual samples per second into the mass detector. Installing simple plate handling automation allowed us to reach a throughput of 100 000 samples per day on a single mass spectrometer. We applied AMI-MS to identify inhibitors of a human histone deacetylase from AstraZeneca's collection of 2 million small molecules and measured their half-maximal inhibitory concentration. The speed, sensitivity, simplicity, robustness, and consumption of nanoliter volumes of sample suggest that this technology will have a major impact across many areas of basic and applied research.

Identifiants

pubmed: 30835099
doi: 10.1021/acs.analchem.9b00142
doi:

Substances chimiques

Histone Deacetylase Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3790-3794

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M017702/1
Pays : United Kingdom

Auteurs

Ian Sinclair (I)

Discovery Sciences, Innovative Medicines and Early Development Biotech Unit , AstraZeneca , Alderley Park , SK10 4TG , U.K.

Martin Bachman (M)

Discovery Sciences, Innovative Medicines and Early Development Biotech Unit , AstraZeneca , Alderley Park , SK10 4TG , U.K.
Discovery Science & Technology , Medicines Discovery Catapult , Alderley Park , SK10 4TG , U.K.

Daniel Addison (D)

Discovery Sciences, Innovative Medicines and Early Development Biotech Unit , AstraZeneca , Cambridge , CB4 0WG , U.K.

Mattias Rohman (M)

Discovery Sciences, Innovative Medicines and Early Development Biotech Unit , AstraZeneca , Mölndal , 431 50 , Sweden.

David C Murray (DC)

Discovery Sciences, Innovative Medicines and Early Development Biotech Unit , AstraZeneca , Alderley Park , SK10 4TG , U.K.

Gareth Davies (G)

Discovery Sciences, Innovative Medicines and Early Development Biotech Unit , AstraZeneca , Alderley Park , SK10 4TG , U.K.

Elizabeth Mouchet (E)

Discovery Sciences, Innovative Medicines and Early Development Biotech Unit , AstraZeneca , Alderley Park , SK10 4TG , U.K.

Michael E Tonge (ME)

Discovery Sciences, Innovative Medicines and Early Development Biotech Unit , AstraZeneca , Cambridge , CB4 0WG , U.K.

Richard G Stearns (RG)

Labcyte Inc. , San Jose , California 95134 , United States.

Lucien Ghislain (L)

Labcyte Inc. , San Jose , California 95134 , United States.

Sammy S Datwani (SS)

Labcyte Inc. , San Jose , California 95134 , United States.

Lars Majlof (L)

Labcyte Inc. , San Jose , California 95134 , United States.

Eric Hall (E)

Labcyte Inc. , San Jose , California 95134 , United States.

Gareth R Jones (GR)

Waters Corporation , Wilmslow , SK9 4AX , U.K.

Emmy Hoyes (E)

Waters Corporation , Wilmslow , SK9 4AX , U.K.

Joe Olechno (J)

Labcyte Inc. , San Jose , California 95134 , United States.

Richard N Ellson (RN)

Labcyte Inc. , San Jose , California 95134 , United States.

Perdita E Barran (PE)

Michael Barber Centre for Collaborative Mass Spectrometry , Manchester Institute of Biotechnology , Manchester , M1 7DN , U.K.

Steven D Pringle (SD)

Waters Corporation , Wilmslow , SK9 4AX , U.K.

Michael R Morris (MR)

Waters Corporation , Wilmslow , SK9 4AX , U.K.

Jonathan Wingfield (J)

Discovery Sciences, Innovative Medicines and Early Development Biotech Unit , AstraZeneca , Cambridge , CB4 0WG , U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH